SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-18-009488
Filing Date
2018-07-20
Accepted
2018-07-20 17:25:26
Documents
1
Group Members
REGALS CAPITAL MANAGEMENT LPREGALS FUND LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D sc13d0718a1regalscap_oramed.htm SC 13D/A 76468
  Complete submission text file 0001213900-18-009488.txt   78008
Mailing Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019 646-844-1164
ORAMED PHARMACEUTICALS INC. (Subject) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: SC 13D/A | Act: 34 | File No.: 005-79895 | Film No.: 18963151
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET, 9TH FLOOR NEW YORK NY 10019
Business Address
Slager David Mark (Filed by) CIK: 0001477733 (see all company filings)

Type: SC 13D/A